As carbon emissions continue to rise and cause the planet to warm up, we need to find ways to reduce them. Capturing carbon at the source of its emission is one of the solutions, but there is still the problem of storing all the carbon sucked out of the atmosphere. If that captured carbon could be put to good use, then perhaps we could have the perfect capturing system in place. This is the line of thinking that researchers at University of California (UCLA) are currently pursuing, and they have some big plans for all that carbon: turning it into concrete.
The conversion of carbon into concrete would be a double whammy since concrete production itself is very planet-unfriendly and accounts for 5 percent of all carbon emissions. But an even larger source of CO2 emissions is flue gas, the combustion exhaust gas from power plants, the scientists' main target.
The carbon would be captured and become the raw material for what they call Co2ncrete, using 3D printers in its fabrication. The researchers describe the multi-stage, complex process, which they are still developing, as upcycling.
A team led by researchers from the UCLA Henry Samueli School of Engineering and Applied Science has created a super-strong yet light structural metal with extremely high specific strength and modulus, or stiffness-to-weight ratio. The new metal is composed of magnesium infused with a dense and even dispersal of ceramic silicon carbide nanoparticles. It could be used to make lighter airplanes, spacecraft, and cars, helping to improve fuel efficiency, as well as in mobile electronics and biomedical devices.
To create the super-strong but lightweight metal, the team found a new way to disperse and stabilize nanoparticles in molten metals. They also developed a scalable manufacturing method that could pave the way for more high-performance lightweight metals. The research was published today in Nature.
“It’s been proposed that nanoparticles could really enhance the strength of metals without damaging their plasticity, especially light metals like magnesium, but no groups have been able to disperse ceramic nanoparticles in molten metals until now,” said Xiaochun Li, the principal investigator on the research and Raytheon Chair in Manufacturing Engineering at UCLA. “With an infusion of physics and materials processing, our method paves a new way to enhance the performance of many different kinds of metals by evenly infusing dense nanoparticles to enhance the performance of metals to meet energy and sustainability challenges in today’s society.”
DARPA has selected two universities to initially lead the agency’s Restoring Active Memory (RAM) program, which aims to develop and test wireless, implantable “neuroprosthetics” that can help servicemembers, veterans, and others overcome memory deficits incurred as a result of traumatic brain injury (TBI) or disease.
The University of California, Los Angeles (UCLA), and the University of Pennsylvania (Penn) will each head a multidisciplinary team to develop and test electronic interfaces that can sense memory deficits caused by injury and attempt to restore normal function. Under the terms of separate cooperative agreements with DARPA, UCLA will receive up to $15 million and Penn will receive up to $22.5 million over four years, with full funding contingent on the performer teams successfully meeting a series of technical milestones. DARPA also has a cooperative agreement worth up to $2.5 million in place with Lawrence Livermore National Laboratory to develop an implantable neural device for the UCLA-led effort.
“The start of the Restoring Active Memory program marks an exciting opportunity to reveal many new aspects of human memory and learn about the brain in ways that were never before possible,” said DARPA Program Manager Justin Sanchez. “Anyone who has witnessed the effects of memory loss in another person knows its toll and how few options are available to treat it. We’re going to apply the knowledge and understanding gained in RAM to develop new options for treatment through technology.”
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.
In a study published in the January issue of the journal Immunity, the researchers describe the novel antiviral property of the protein, cholesterol-25-hydroxylase (CH25H), an enzyme that converts cholesterol to an oxysterol called 25-hydroxycholesterol (25HC), which can permeate a cell's wall and block a virus from getting in.
Interestingly, the CH25H enzyme is activated by interferon, an essential antiviral cell-signaling protein produced in the body, said lead author Su-Yang Liu, a student in the department of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA.
"Antiviral genes have been hard to apply for therapeutic purposes because it is difficult to express genes in cells," said Liu, who performed the study with principal investigator Genhong Cheng, a professor of microbiology, immunology and molecular genetics. "CH25H, however, produces a natural, soluble oxysterol that can be synthesized and administered.
"Also, our initial studies showing that 25HC can inhibit HIV growth in vivo should prompt further study into membrane-modifying cholesterols that inhibit viruses," he added.
The discovery is particularly relevant to efforts to develop broad-spectrum antivirals against an increasing number of merging viral pathogens, Liu said.
Working with Jerome Zack, a professor of microbiology, immunology and molecular genetics and an associate director of the UCLA AIDS Institute, the researchers initially found that 25HC dramatically inhibited HIV in cell cultures. Next, they administered 25HC in mice implanted with human tissues and found that it significantly reduced their HIV load within seven days. The 25HC also reversed the T-cell depletion caused by HIV.
